GO
Loading...

Enter multiple symbols separated by commas

Drug Retail

More

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, to enter the business of administering drug benefits for employers. The third-largest U.S. drug-store chain said it would pay about $1.8 billion in cash and $200 million in stock. Rite Aid's shares rose 3 percent to $7.88 in premarket trading.

  • Feb 10- CVS Health Corp reported a better-than-expected quarterly net revenue, boosted by growth in its Medicaid business and strength in specialty drug sales. CVS became the first national drugstore chain in the United States to take cigarettes off its shelves from Oct. 1. CVS Health has focused on developing its specialty pharmacy business, which sells drugs...

  • Feb 10- CVS Health Corp, the No. 2 U.S. drugstore operator, reported a better-than-expected quarterly net revenue, helped by a jump in pharmacy same-store sales and strength in its specialty pharmacy business. CVS Health has focused on developing its specialty pharmacy business, which sells drugs to treat complex diseases such as multiple sclerosis, rheumatoid...

  • Orexigen CEO: Excited about obesity drug progress Tuesday, 13 Jan 2015 | 2:22 PM ET
    Orexigen CEO: Excited about obesity drug progress

    Mike Narachi, Orexigen CEO, speaks with CNBC's Meg Tirrell about its obesity drug and program.

  • Biogen Idec beefs up pain pipeline Monday, 12 Jan 2015 | 3:16 PM ET
    Biogen Idec beefs up pain pipeline

    Dr. George Scangos, Biogen Idec CEO, discusses new therapies in multiple sclerosis, Alzheimer's disease and pain.

  • SHANGHAI, Jan 9- China will allow online sales of prescription drugs as early as this month, a policy that will open up an over 1 trillion yuan market to online pharmacy operators like Alibaba Group Holding Ltd and Wal-Mart Stores Inc.. The policy would help reform a fragmented and opaque market controlled by state-run distributors and hospitals, brought into...

  • Walgreens December same-store sales beat estimates Tuesday, 6 Jan 2015 | 11:35 AM ET

    Jan 6- Walgreen Co, the largest U.S. pharmacy chain, reported a better-than-expected jump in December comparable store sales, helped by the month containing one more Wednesday and one fewer Sunday than a year ago and higher sales of flu medicine. Walgreen, which gets more than 60 percent of its revenue from prescription drug sales, also sells non-prescription...

  • America going to pot Friday, 2 Jan 2015 | 10:48 AM ET
    America's going to pot

    CNBC's Jane Wells shares her top three predictions for the pot industry this year, including changing bank regulations and the beginning of voters' remorse where it's legal.

  • Walgreen profit rises 16% on record prescriptions Tuesday, 23 Dec 2014 | 9:23 AM ET
    A Walgreens store is shown in Homestead, Fla.

    U.S. drugstore chain operator Walgreen reported a 16 percent rise in quarterly profit, helped by a record number of prescriptions filled.

  • Lottery ticket sector of 2015 Monday, 22 Dec 2014 | 12:46 PM ET
    Lottery ticket sector of 2015

    Mark Fisher, MBF Clearing Corp. chairman, shares his favorite stock in the biotech space.

  • Cramer's view of AbbVie-Express Scripts deal Monday, 22 Dec 2014 | 8:52 AM ET
    Cramer's view of AbbVie-Express Scripts deal

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.

  • Express Scripts' significant discount on hep C drug Monday, 22 Dec 2014 | 8:50 AM ET
    Hepatitis C virus

    Express Scripts Medical Chief Steve Miller, provides insight to his company's deal with AbbVie. The two companies have come to a deal which gives Express Scripts a significant discount on the hepatitis C drug.

  • Express Scripts gets deal for AbbVie's hepatitis C drug

    CNBC's Meg Tirrell provides insight to a newly approved hepatitis C drug from AbbVie, which Express Scripts made an exclusive deal for a significant discount on the drug.

  • Intercept CEO: NASH epidemic of liver disease Friday, 14 Nov 2014 | 3:16 PM ET
    Intercept CEO: NASH epidemic of liver disease

    Intercept Pharmaceuticals CEO Mark Pruzanski, provides insight to his company's efforts to tackle NASH, or nonalcoholic steatohepatitis, saying over 10 percent of the U.S. population is thought to have NASH. Pruzanski also weighs in on being a public company.

  • Lots of risk in biotech: Pro Monday, 10 Nov 2014 | 2:22 PM ET
    Lots of risk in biotech: Pro

    Discussing warning signs from Dendreon, and other worrisome companies, with Les Funtleyder, E Square Asset Management.

  • Dendreon declares bankruptcy Monday, 10 Nov 2014 | 2:18 PM ET
    Dendreon declares bankruptcy

    Joseph Pantginis, Roth Capital, has been negative on Dendreon for a long time, ahead of the drugmaker's bankruptcy protection filing.

  • Supermarket sweep: What could lift Kroger shares Monday, 3 Nov 2014 | 12:37 PM ET
    A shopper outside a Kroger supermarket in Peoria, Illinois.

    Kroger has delivered 43 straight quarters of rising sales at stores open at least a year.

  • Drugmakers want indemnity Thursday, 23 Oct 2014 | 1:38 PM ET
    Drugmakers want indemnity

    Drug companies may be looking for legal protection amid a massive demand for Ebola vaccines, reports CNBC's Meg Tirrell.

  • Former Walgreen CFO sues company for defamation Friday, 17 Oct 2014 | 7:59 AM ET

    Walgreen's former CFO sued the drugstore operator, alleging executives defamed him in news reports that blamed him for errors in its forecast.

  • GW Pharma: Focused on epilepsy Tuesday, 14 Oct 2014 | 5:22 PM ET
    GW Pharma: Focused on epilepsy

    GW Pharma shares are down sharply after a study of its treatment for ulcerative colitis missed its primary endpoint in a mid-stage trial. GW Pharmaceuticals CEO Justin Gover, says the company's main focus is on its product for epilepsy.